Summary: Middle-aged adults who report chronic insomnia or sleep durations under six hours show about double the likelihood of measurable cognitive impairment compared with those who sleep well. The link is stronger when cardiometabolic conditions are present.
Source: Penn State
Middle-aged adults who describe symptoms of insomnia and who sleep less than six hours per night have a higher risk of cognitive impairment, according to research from Penn State College of Medicine. These findings can help clinicians identify which patients reporting insomnia may be at greater risk for future dementia.
Insomnia includes difficulty falling asleep, trouble staying asleep, or waking too early and being unable to return to sleep. When these symptoms occur at least three nights per week for three months or longer, they are classified as chronic insomnia.
In this study, adults who reported insomnia and who were observed to sleep less than six hours during a laboratory-monitored night were about twice as likely to have cognitive impairment compared with people who reported insomnia but slept six or more hours in the lab.
The results were published in the journal Sleep.
Julio Fernandez-Mendoza, associate professor of psychiatry and behavioral health and a sleep specialist at Penn State Health Sleep Research and Treatment Center, notes that roughly one-quarter of adults report insomnia symptoms and about 10% suffer from chronic insomnia. Distinguishing which individuals with insomnia are at elevated risk for other health problems is crucial for targeted care.
“This study emphasizes the importance of objectively assessing sleep in adults who report insomnia,” Fernandez-Mendoza said.
Earlier work by the team linked insomnia combined with short sleep duration to higher risks of cardiometabolic conditions such as hypertension, diabetes, heart disease, and stroke, as well as to mental health problems including depression.
“These new findings show that middle-aged adults with insomnia who sleep less than six hours in the lab also face greater risk of cognitive impairment, which in many cases can be an early sign of future dementia,” Fernandez-Mendoza added.
Researchers analyzed data from the Penn State Adult Cohort, a population-based, randomly selected sample of 1,741 adults who underwent one night of laboratory sleep measurement. Before the overnight study, participants completed a clinical history, physical exam, and questionnaires to capture self-reported sleep complaints, medical conditions, mental health status, and substance use.
Participants also completed a cognitive assessment before the sleep study that evaluated attention, memory, language, and other cognitive domains.
The investigators found that participants who reported insomnia symptoms or chronic insomnia and who slept less than six hours during the monitored night were approximately twice as likely to show cognitive impairment compared with participants who reported good sleep.
The association between short sleep, insomnia, and cognitive impairment was especially pronounced in adults with existing cardiometabolic diseases, a pattern that may reflect vascular contributions to cognitive decline—where compromised cardiovascular health affects brain function.
Importantly, adults who reported insomnia but slept six or more hours in the laboratory did not exhibit higher risk of cognitive impairment compared with good sleepers. The research team adjusted analyses for sociodemographic factors (age, sex, race, ethnicity, education), medical and psychiatric conditions, obstructive sleep apnea, and substance use such as smoking and alcohol consumption.
Fernandez-Mendoza cautioned that having only one recorded night of sleep limits the findings to laboratory-measured sleep and that the data do not establish causation. Still, the results reinforce that insomnia, cognitive impairment, and cardiometabolic diseases frequently co-occur in adults who get less than six hours of sleep in the lab, whereas those who can sleep six hours or more appear less likely to show this clustering of conditions.
Michael Twery, director of the National Center on Sleep Disorders Research at the National Heart, Lung, and Blood Institute, noted the study’s significance as the first large U.S. prospective investigation linking insomnia with cognitive risk. He emphasized that growing evidence shows the brain depends on sleep and that clarifying how sleep deficiency contributes to early cognitive decline could lead to better insomnia treatments and strategies to protect brain health.
About this sleep research article
Source:
Garvan Institute of Medical Research
Contacts:
Zachary Sweger – Penn State
Image Source:
The image is in the public domain.
Original Research:
Open access — “Evidence for the Etiopathogenesis of Insomnia and its Psychiatric Risk” by Julio Fernandez-Mendoza. Sleep. DOI: 10.5665/sleep.3906
Abstract
Evidence for the Etiopathogenesis of Insomnia and its Psychiatric Risk
In this issue of Sleep, Drake and colleagues present the first longitudinal community-based study to examine how sleep reactivity—a trait measured by the Ford Insomnia Response to Stress Test—predicts vulnerability to insomnia and later depression. Decades of research indicate that insomnia often develops after stressful life events in people who are predisposed to poor sleep. Early models proposed that emotional vulnerability and inadequate coping increase the likelihood that stress triggers lasting sleep problems. Subsequent diathesis-stress and hyperarousal models further suggested that both situational and trait factors, including heightened arousability, influence the transition from transient sleep disruption to chronic insomnia. Until recently, however, few prospective studies had evaluated premorbid traits that place individuals at risk for chronic insomnia or tracked how temporary insomnia evolves into a long-term disorder. The work summarized here adds important longitudinal evidence linking pre-existing vulnerability to later insomnia and associated psychiatric risk.